摘要:
A cembranoid compound of the following formula (I) as described herein. The compounds of the present invention are useful as chemopreventive and chemotherapeutic agents.
摘要:
Lewis acid-catalysed reaction of alkenes (including cycloalkenes) with an epoxide is a novel reaction useful for synthesis of various fragrance materials (known and novel) and their intermediates.
摘要:
Die vorliegende Erfindung betrifftgemäß einem primären Aspekt ein Verfahren zur Herstellung einer Mischung umfassend Rotundon. Ein weiterer Aspekt der vorliegenden Erfindung betrifft Rotundon-haltige Mischungen sowie deren Verwendung zum Erzeugen, Vermitteln oder Modifizieren, vorzugsweise Verstärken, eines oder mehrerer Geschmacks-und/oder Geruchseindrücke. Die Erfindung betrifft zudem eine der Ernährung, der Mundpflege oder dem Genuss dienende oder kosmetische oder zur oralen Aufnahme bestimmte pharmazeutische Zubereitung oder Halbfertigware zur Herstellung einer der Ernährung, der Mundpflege oder dem Genuss dienenden oder kosmetischen oder zur oralen Aufnahme bestimmten pharmazeutischen Zubereitung, umfassend eine erfindungsgemäße Mischungsowie des Weiteren ein Verfahren zur Herstellung besagter Zubereitung oder Halbfertigware.
摘要:
The use as fragrance ingredient of a compound of formula (I) wherein R 1 and Y have the same meaning as given in the description, and fragrance applications comprising them.
摘要:
A process for preparation of protriptyline hydrochloride from 5- dihydrobenzocycloheptatriene of formula (1) by coupling with chloropropyl alcohol in the presence of excess n-butyl Lithium in tetrahydrofuran under inert atmosphere, followed by preparation of mesylate derivative of formula (3) and finally the nucleophilic displacement of the mesylate group by reacting methylamine solution in methanol to give protriptyline free base of the formula (4). Also the present process reveals the hydrochloride salt formation and purification of the same to give pure pharmaceutical grade protriptyline hydrochloride with impurities less than 0.1%w/w.
摘要:
The present invention relates to a urea compound of formula (1) and a pharmaceutically acceptable salt thereof having inhibitory activity of ATM and ATR. According to the present invention, the urea compound of formula (1) selectively binds to ATM and ATR, and thus specifically suppresses the function of ATM and ATR as protein kinase. Therefore, the urea compound according to the present invention can be used for controlling cell function and treating diseases, in connection with function abnormality in ATM and ATR
摘要:
The invention relates to fused cyclooctyne compounds, and to a method for their preparation. The invention also relates to a conjugate wherein a fused cyclooctyne compound according to the invention is conjugated to a label,and to the use of these conjugates in bioorthogonal labeling, imaging and/or modification, such as for example surface modification,of a target molecule. The invention further relates to a method for the modification of a target molecule, wherein a conjugate according to the invention is reacted with a compound comprising a 1,3-dipole or a 1,3-(hetero)diene.